$6.67
0.15% yesterday
Nasdaq, Dec 24, 07:01 pm CET
ISIN
US45780L1044
Symbol
INGN

Inogen, Inc. Stock price

$6.67
-0.41 5.79% 1M
-0.38 5.39% 6M
-2.50 27.26% YTD
-1.76 20.88% 1Y
-13.25 66.52% 3Y
-36.65 84.60% 5Y
-34.93 83.97% 10Y
-8.48 55.97% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
-0.01 0.15%

Key metrics

Basic
Market capitalization
$181.1m
Enterprise Value
$57.9m
Net debt
positive
Cash
$123.2m
Shares outstanding
27.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.5 | 0.5
EV/Sales
0.2 | 0.2
EV/FCF
negative
P/B
0.9
Financial Health
Equity Ratio
58.7%
Return on Equity
-20.6%
ROCE
-12.1%
ROIC
-20.9%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$347.0m | $362.7m
EBITDA
$-8.6m | $1.9m
EBIT
$-29.3m | $-32.0m
Net Income
$-25.4m | $-26.3m
Free Cash Flow
$-24.4m
Growth (TTM | estimate)
Revenue
4.7% | 8.0%
EBITDA
76.3% | 105.6%
EBIT
49.0% | 17.3%
Net Income
51.8% | 26.7%
Free Cash Flow
-68.9%
Margin (TTM | estimate)
Gross
44.8%
EBITDA
-2.5% | 0.5%
EBIT
-8.5%
Net
-7.3% | -7.3%
Free Cash Flow
-7.0%
More
EPS
$-0.9
FCF per Share
$-0.9
Short interest
2.8%
Employees
766
Rev per Employee
$440.0k
Show more

Is Inogen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Inogen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Inogen, Inc. forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Inogen, Inc. forecast:

Buy
88%
Hold
13%

Financial data from Inogen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
347 347
5% 5%
100%
- Direct Costs 192 192
4% 4%
55%
155 155
6% 6%
45%
- Selling and Administrative Expenses 165 165
9% 9%
47%
- Research and Development Expense 20 20
11% 11%
6%
-8.63 -8.63
76% 76%
-2%
- Depreciation and Amortization 21 21
2% 2%
6%
EBIT (Operating Income) EBIT -29 -29
49% 49%
-8%
Net Profit -25 -25
52% 52%
-7%

In millions USD.

Don't miss a Thing! We will send you all news about Inogen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inogen, Inc. Stock News

Positive
Seeking Alpha
about one month ago
Inogen (INGN) continues its turnaround, showing progress in revenue growth and margins, but the pace remains slower and riskier than the market desires. INGN posted positive adjusted EBITDA and raised full-year guidance, despite mixed quarterly results and ongoing volatility in direct-to-consumer and rental segments. The company's strong market position, new product launches, and partnerships o...
Neutral
Seeking Alpha
about 2 months ago
Inogen, Inc. ( INGN ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Lorna Williams Kevin Smith - President, CEO & Director Michael Bourque - Executive VP, CFO & Corporate Treasurer Conference Call Participants Joseph Conway - Needham & Company, LLC, Research Division Anderson Schock - B. Riley Securities, Inc., Research Division Presentation Operator Welcome to Inogen'...
Neutral
Business Wire
about 2 months ago
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Third Quarter 2025 Financial Results Delivered seventh consecutive quarter of mid-single-digit revenue growth.
More Inogen, Inc. News

Company Profile

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Head office United States
CEO Kevin Smith
Employees 766
Founded 2001
Website www.inogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today